These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21824992)

  • 1. Abilities of candesartan and other AT(1) receptor blockers to impair angiotensin II-induced AT(1) receptor activation after wash-out.
    Kiya Y; Miura S; Matsuo Y; Karnik SS; Saku K
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):76-83. PubMed ID: 21824992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.
    Miura S; Okabe A; Matsuo Y; Karnik SS; Saku K
    Hypertens Res; 2013 Feb; 36(2):134-9. PubMed ID: 23034464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of the new AT1 receptor blocker azilsartan to block angiotensin II-induced AT1 receptor activation after wash-out.
    Miura S; Matsuo Y; Nakayama A; Tomita S; Suematsu Y; Saku K
    J Renin Angiotensin Aldosterone Syst; 2014 Mar; 15(1):7-12. PubMed ID: 23563275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males.
    Zimmerman MA; Harris RA; Sullivan JC
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1136-42. PubMed ID: 24647710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
    Le MT; Pugsley MK; Vauquelin G; Van Liefde I
    Br J Pharmacol; 2007 Aug; 151(7):952-62. PubMed ID: 17572702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AT1 receptor blocker potentiates shear-stress induced nitric oxide production via modulation of eNOS phosphorylation of residues Thr(495) and Ser(1177.).
    Barauna VG; Mantuan PR; Magalhães FC; Campos LC; Krieger JE
    Biochem Biophys Res Commun; 2013 Nov; 441(4):713-9. PubMed ID: 24211212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Montón M; Jiménez A; Núñez A; López-Blaya A; Farré J; Gómez J; Zalba LR; Sánchez de Miguel L; Casado S; López-Farré A
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):906-13. PubMed ID: 10836725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.
    Vanderheyden PM; Fierens FL; De Backer J; Vauquelin G
    Biochem Pharmacol; 2000 Apr; 59(8):927-35. PubMed ID: 10692557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries.
    Pantev E; Stenman E; Wackenfors A; Edvinsson L; Malmsjö M
    Eur J Heart Fail; 2002 Dec; 4(6):699-705. PubMed ID: 12453539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.
    Bhuiyan MA; Hossain M; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2010; 112(4):459-62. PubMed ID: 20308802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional antagonism of different angiotensin II type I receptor blockers in human arteries.
    Wagenaar LJ; Voors AA; Buikema H; van Buiten A; Lübeck RH; Boonstra PW; van Veldhuisen DJ; van Gilst WH
    Cardiovasc Drugs Ther; 2002 Jul; 16(4):311-6. PubMed ID: 12652100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):209-217. PubMed ID: 30370429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
    Wang QD; Sjöquist PO
    Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?
    Unger T
    Am J Cardiol; 1999 Nov; 84(10A):9S-15S. PubMed ID: 10588089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
    Tsutamoto T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.